NextGen Biomed Ltd. Logo

NextGen Biomed Ltd.

R&D of biotech medical devices for diabetes care and topical skin treatments.

NXGN | TA

Overview

Corporate Details

ISIN(s):
IL0010839301
LEI:
Country:
Israel
Address:
132 Azrieli Towers Round Building Menachem Begin Street P.O. Box 14, 6701101 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

NextGen Biomed Ltd. is a research and development company operating in the biotechnology and medical device sectors. The company focuses on developing products such as the EyePen, an injection module designed for individuals with diabetes to monitor insulin dosage and timing. Its portfolio also includes pain-free auto-injectors, lancet devices, and the development of topical treatments for conditions like psoriasis. The company was formerly known as Sela Group.Com Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-30 18:01
Regulatory News Service
Trading in the company's shares (ISIN IL0010839301) will be renewed on Tuesday,…
Hebrew (modern) 158.5 KB
2024-05-01 10:36
Regulatory News Service
Trading in the company's shares has been suspended since the company has not ye…
Hebrew (modern) 78.8 KB
2024-04-18 19:36
Regulatory News Service
Suspension of trade due to failure in publishing financial reports-Notification
Hebrew (modern) 129.9 KB
2021-01-12 18:34
Regulatory News Service
On January 14, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 251.9 KB

Automate Your Workflow. Get a real-time feed of all NextGen Biomed Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NextGen Biomed Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel HRON
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom HVO
Iconovo AB Logo
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden ICO
IMMUPHARMA PLC Logo
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom IMM
Inhalation Sciences Sweden AB Logo
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden ISAB
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
LYSOGENE Logo France LYS
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.